Medical News |
- Social cognition reduced in FEP, UHR patients
- Intermittent hormone therapy effective for prostate cancer patients
- 'No malignancy risk' with biologic response modifiers
- Plasma biomarker predicts rheumatoid arthritis onset
| Social cognition reduced in FEP, UHR patients Posted: 12 Sep 2012 05:00 PM PDT First-episode psychosis patients show widespread impairments in social cognition, and such impairments are also evident, albeit to a lesser extent, in those at ultra-high risk for psychosis, researchers report. |
| Intermittent hormone therapy effective for prostate cancer patients Posted: 09 Sep 2012 05:00 PM PDT Intermittent androgen deprivation is as effective as continuous therapy for men with rising prostate-specific antigen levels after primary or salvage radiotherapy, say researchers who believe the break from treatment improves quality of life. |
| 'No malignancy risk' with biologic response modifiers Posted: 09 Sep 2012 05:00 PM PDT Rheumatoid arthritis patients treated with biologic response modifiers for at least 6 months do not have a greater risk for malignancy than those given other disease-modifying drugs or placebo, conclude US and Spanish researchers. |
| Plasma biomarker predicts rheumatoid arthritis onset Posted: 09 Sep 2012 05:00 PM PDT Healthy individuals with high levels of immunoglobulin G rheumatoid factor have a significantly increased risk for developing rheumatoid arthritis, suggests population-based research published in the BMJ. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment